Completed
A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
NCT01031472
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States